Allergan rolls out IBS drug Viberzi
DUBLIN, Ireland — Allergan plc has released Viberzi (eluxadoline), a treatment for irritable bowel syndrome with diarrhea (IBS-D), to U.S. pharmacies. The company said Monday that Viberzi, a twice-daily oral medication, relieves the core symptoms of IBS-D: recurrent diarrhea and abdominal pain. Symptom relief was maintained throughout treatment in two pivotal clinical trials. “We are excited about the launch of Viberzi, which
